APR 13, 2017 1:30 PM PDT

Ultra-sensitive single-molecule array (Simoa) technology to revolutionize CNS biomarkers

Speaker

Abstract

The presentation will describe the principles of the ultra-sensitive single-molecule array (Simoa) developed by Quanterix and the application of the Simoa technology to the development of a toolbox of CNS biomarkers. The presentation will include several case studies across CNS diseases, ranging from traumatic brain injury to Alzheimer's Disease


You May Also Like
APR 13, 2017 1:30 PM PDT

Ultra-sensitive single-molecule array (Simoa) technology to revolutionize CNS biomarkers



Loading Comments...